Consent decree issued against recalcitrant compounder

The FDA has secured a consent decree against a Texas compounder that had questioned FDA authority over its operations. The FDA says that a federal judge issued the consent decree last week against Downing Labs of Dallas, co-owners Ashley Michelle Downing and Christopher Van Downing, and pharmacist-in-charge Roger Mansfield. Downing Labs, formerly known as NuVision Pharmacy, had continued to manufacture adulterated drugs even after repeated warnings from the FDA, the regulator said. The compounder, which had resisted FDA pressure to recall all of its sterile drugs, finally relented last fall. Release | More

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.